prednisone has been researched along with epirubicin in 165 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (3.64) | 18.7374 |
| 1990's | 56 (33.94) | 18.2507 |
| 2000's | 69 (41.82) | 29.6817 |
| 2010's | 29 (17.58) | 24.3611 |
| 2020's | 5 (3.03) | 2.80 |
| Authors | Studies |
|---|---|
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Foà, R; Gavosto, F; Monfardini, S; Tirelli, U; Vaccher, E | 1 |
| Blanc, CM; David, B; Eghbali, H; Hoerni, B; Orgerie, MB; Rojouan, J; Zittoun, R | 2 |
| Bastion, Y; Coiffier, B; Tigaud, JD | 1 |
| Smeets, J; Wils, J | 1 |
| Kuikka, J; Lahtinen, R; Länsimies, E; Nousiainen, T; Uusitupa, M | 1 |
| Bisail, M; Cassisa, L; Casula, S; Fele, G; Malavasi, A; Manca, M | 1 |
| Blatsios, V; Bouros, D; Emmanouel, A; Niotis, M | 1 |
| Aitini, E; Amurri, B; Bocchia, M; Cavazzini, G; Gherlinzoni, F; Gobbi, M; Mazza, P; Tura, S; Zanchini, R; Zinzani, PL | 1 |
| Brandwein, JM; Callum, J; Keating, A; Scott, JG; Sutcliffe, SB | 1 |
| Audebert, A; Blanc, CM; David, B; Debray, J; Eghbali, H; Hoerni, B; Rojouan, J; Zittoun, R | 1 |
| Brandi, M; Calabrese, P; De Lena, M; Lorusso, V; Maiello, E; Marzullo, F; Mazzei, A; Romito, S | 1 |
| Al-Ismail, SA; Gough, J; Whittaker, JA | 1 |
| Abate, G; Basso, A; Comella, P; Di Pietro, N; Ganzina, F; Pergola, M; Salvatore, M; Silvestro, P; Zarrilli, D | 1 |
| Gabryś, K; Kotlarek-Haus, S; Potoczek, S | 1 |
| Carde, P | 1 |
| Bonadonna, G; Bregni, M; Di Nicola, M; Gandola, L; Gianni, AM; Lombardi, F; Magni, M; Peccatori, F; Siena, S; Valagussa, P | 1 |
| Barrantes, JC; Barrantes, M; García, I; González, M; Jiménez, R; Lobo-Sanahuja, F | 1 |
| Carde, P; Dupouy, N; Eghbali, H; Mandard, AM; Mellink, WA; Monconduit, M; Noordijk, EM; Somers, R; Thomas, J; Tirelli, U | 1 |
| Fosså, SD; Paus, E | 1 |
| Alatriste, S; Avilés, A; Delgado, S; Díaz-Maqueo, JC; Nambo, MJ | 1 |
| Bonfante, V; Castellani, MR; Devizzi, L; Negretti, E; Santoro, A; Soncini, F; Villani, F; Viviani, S; Zanini, M; Zucali, R | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Nambo, MJ; Talavera, A | 1 |
| Bertini, M; Botto, B; Freilone, R; Gavarotti, P; Levis, A; Orlandi, E; Orsucci, L; Pini, M; Pizzuti, M; Vitolo, U | 1 |
| Avilés, A; Delgado, S; Fernández, A; Nambo, MJ; Rosas, A | 1 |
| Brandi, M; De Lena, M; Ditonno, P; Lorusso, V; Marzullo, F; Pellecchia, A; Timurian, A; Ventrella, V | 1 |
| Boiocchi, M; Carbone, A; Dolcetti, R; Errante, D; Franceschi, S; Gloghini, A; Serraino, D; Tirelli, U; Vaccher, E | 1 |
| Arreguín, L; Benítez, H; Bernaldez, R; Díaz, S; Farfán, J; Gaona, A; Juan, L; Martínez, MC; Velásquez, L | 1 |
| Aydiner, A; Buğra, Z; Meriç, M; Topuz, E | 1 |
| Avanzini, P; Cavanna, L; Di Renzo, N; Federico, M; Gobbi, PG; Grignani, G; Iannitto, E; Narni, F; Partesotti, G; Pieresca, C | 1 |
| Bertini, M | 1 |
| Battista, C; Bevilacqua, N; Chiurazzi, B; Cocorocchio, E; Esposito, G; Iodice, G; Pacilio, G; Panza, N | 1 |
| Connors, JM; Hoskins, P; Howdle, S; Klasa, R; Klimo, P; O'Reilly, SE; Stuart, DS | 1 |
| Koralewski, P; Pawlicki, M; Rolski, J | 1 |
| Arévila, N; Avilés, A; Díaz Maqueo, JC; García, R; Gómez, T; Nambo, MJ | 1 |
| Bolognesi, A; Ferreri, AJ; Reni, M; Verusio, C; Villa, E | 1 |
| Avanzini, P; Carotenuto, M; Cavanna, L; Federico, M; Frassoldati, A; Gobbi, PG; Lombardo, M; Pieresca, C; Silingardi, V; Vallisa, D | 1 |
| Ascari, E; Barbarano, L; Bergonzi, C; Brugnatelli, S; De Paoli, A; Di Stasi, M; Mora, O; Petrini, M; Piccinini, L; Piva, N; Riccardi, A; Rinaldi, E; Trotti, G; Ucci, G | 1 |
| Furusawa, S; Hatake, K; Hoshino, Y; Izumi, T; Komatsu, N; Miura, Y; Muroi, K; Ohtsuki, T; Tomizuka, H; Yamada, M | 1 |
| Haynes, AP; Iqbal, A; McQuaker, IG; Russell, NH | 1 |
| Aviles, A; Duque, G; Guzman, R; Talavera, A | 1 |
| Bertini, M; Botto, B; Cinieri, S; Ciotti, R; Di Nota, A; Di Vito, F; Freilone, R; Levis, A; Orsucci, L; Pini, M; Resegotti, L; Rota-Scalabrini, D; Todeschini, G; Vitolo, U | 1 |
| Behringer, D; Fetscher, S; Finke, J; Kanz, L; Lange, W; Lübbert, M; Mertelsmann, R | 1 |
| Dubowik, R; Gabryś, K; Urbaniak-Kujda, D | 1 |
| Abd El-Warith, A; Berry, J; Ezzat, AA; Khan, BA; Raja, MA; Rhydderch, DC | 1 |
| Keinànen, S; Laine, P; Lindqvist, C; Meurman, JH; Pyrhönen, S; Teerenhovi, L | 1 |
| Avilés, A; Calva, A; Díaz-Maqueo, JC; Huerta-Guzmán, J; Talavera, A; Vásquez, E | 1 |
| Bernáldez-Ríos, R; Espinoza-Hernández, L; Fajardo-Gutíerrez, A; Martínez-García, MC; Mejía-Arangure, JM; Rodríguez-Zepeda, MC | 1 |
| Avilés, A; Díaz Maqueo, JC; Garcia, EL; Huerta-Guzman, J; Nambo, MJ; Talavera, A | 1 |
| Hanazawa, T; Kimura, Y; Nagumo, M; Okano, T; Sakamaki, H; Yamaguchi, A | 1 |
| Balzarotti, M; Bonadonna, G; Bonfante, V; Camerini, E; Devizzi, L; Fornier, M; Santoro, A; Valagussa, P; Verderio, P; Viviani, S | 1 |
| Davis, AJ; Goldstein, D; Milliken, S | 1 |
| Botto, F; Lionetto, R; Pensa, F; Pronzato, P; Tognoni, A | 1 |
| Avanzini, P; Baldini, L; Brugiatelli, M; Carotenuto, M; Clò, V; Di Renzo, N; Dini, D; Federico, M; Gobbi, PG; Lombardo, M; Silingardi, V; Vallisa, D | 1 |
| Dalay, N; Inanc, S; Onat, H; Saip, P; Yalcinkaya, L; Yazici, H | 1 |
| Carbone, A; Errante, D; Gabarre, J; Gisselbrecht, C; Kerneis, Y; Mazzetti, F; Nosari, AM; Ridolfo, AL; Rossi, G; Talamini, R; Tirelli, U; Vaccher, E | 1 |
| Chim, CS; Kwong, YL; Lee, CK; Liang, R; Lie, AK | 1 |
| Bauduer, F; Coiffier, B; Desablens, B | 1 |
| Bargetzi, M; Heitzmann, F; Obeid, L; Schär, B | 1 |
| Abate, G; Bianco, AR; Catalano, G; D'Aprile, M; Dammacco, F; De Lena, M; De Vita, F; Lauta, VM; Lorusso, V; Lucarelli, G; Mantovani, G; Marzullo, F; Palmieri, G; Polimeno, G | 1 |
| Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP | 1 |
| Chan, JK; Cheung, MM; So, JC; Wong, KF | 1 |
| Albertini, P; Alinari, L; Bendandi, M; Gherlinzoni, F; Stefoni, V; Tani, M; Tura, S; Vigna, E; Zinzani, PL | 1 |
| Artusi, T; Bonacorsi, G; Longo, L; Rivasi, F; Rossi, G | 1 |
| Genvresse, I; Harder, H; Lange, C; Possinger, K; Schanz, J; Schweigert, M; Späth-Schwalbe, E | 1 |
| Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C | 1 |
| Bollas, G; Dervenoulas, J; Economopoulos, T; Kalantzis, D; Koumarianou, A; Mantzios, G; Papageorgiou, E; Raptis, S; Rontogianni, D; Tsirigotis, P | 1 |
| Avilés, A; Díaz-Maqueo, JC; García, EL; Neri, N; Talavera, A | 1 |
| Dimopoulos, MA; Economopoulos, T; Fountzilas, G; Mellou, S; Nicolaides, C; Papadopoulos, A; Papageogriou, E; Papasavvas, P; Pavlidis, N; Samantas, E; Tsatalas, C | 1 |
| Bergmann, M; Busch, R; Emmerich, B; Franke, A; Hallek, M; Hiddemann, W; Hopfinger, G; Pasold, R; Schlag, R; Schmitt, B; Wendtner, CM | 1 |
| Avilés, A; Díaz-Maqueo, JC; Fernández, R; García, EL; Gonzalez, JL; Neri, N | 1 |
| Franchini, M; Krampera, M; Pizzolo, G; Veneri, D; Zanetti, F | 1 |
| Connolly, DL; Davis, RC; Hamaad, A | 1 |
| Colombat, P; Desablens, B; Escoffre, M; Gandhour, C; Haillot, O; Harousseau, JL; Jacob, C; Le Prise, PY; Lefrancq, T; Leloup, R; Linassier, C; Lucas, V; Tabuteau, S | 1 |
| Avilés, A; Calva, A; Fernández, R; Huerta-Guzmán, J; Nambo, MJ; Neri, N | 1 |
| Buse, G; Zanssen, S | 1 |
| Baldini, L; Brugiatelli, M; Cavanna, L; Colombi, M; Federico, M; Gobbi, P; Goldaniga, M; Liberati, M; Lombardo, M; Luminari, S; Merli, F; Morabito, F; Sacchi, S; Silingardi, V; Stelitano, C | 1 |
| Abdelkefi, M; Belcadhi, M; Bouzouita, H; Bouzouita, K; el Omri, H; Ennabli, S; Gnaba, K; Mani, R | 1 |
| Gillett, M; Haak, S | 1 |
| Hadjileontis, CG; Kaloutsi, VD; Kostopoulos, IS; Kotoula, VA; Nikolaou, AC; Papadimitriou, CS | 1 |
| Bouabdallah, R; Brice, P; Brière, J; Le Gouill, S; Lepage, E; Lepretre, S; Morel, P; Raffoux, E; Sebban, C | 1 |
| Manca, E; Miccolis, I; Perego, D; Pogliani, EM; Rivolta, F; Rossini, F; Terruzzi, E | 1 |
| Berthou, C; Colombat, P; Deconinck, E; Delwail, V; Foussard, C; Gaillard, F; Gressin, R; Harousseau, JL; Lucas, V; Milpied, N | 1 |
| Chen, TY; Huang, WT; Leaw, SJ; Su, WC; Tsao, CJ; Yen, CJ | 1 |
| Aebersold, DM; Altermatt, HJ; Berclaz, G; Djonov, V; Greiner, RH; Gruber, G; Hlushchuk, R | 1 |
| Buitendijk, S; Hählen, K; Hakvoort-Cammel, FG; van den Heuvel-Eibrink, M | 1 |
| Anargyrou, K; Angelopoulou, MK; Boussiotis, VA; Boutsis, DE; Dimopoulou, MN; Karkantaris, C; Kokoris, SI; Kontopidou, FN; Kyrtsonis, MC; Michalopoulos, T; Panayiotidis, P; Pangalis, GA; Papavassiliou, C; Siakantaris, MP; Tsaftaridis, P; Variamis, E; Vassilakopoulos, TP | 1 |
| Bertè, R; Bertini, M; Botto, B; De Paoli, A; Federico, M; Luminari, S; Merli, F; Mozzana, R; Pizzuti, M; Quintana, G; Stelitano, C; Trottini, M | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Fernándezb, R; González, M; Nambo, MJ; Neri, N; Pérez, F; Talavera, A | 1 |
| Balzarini, L; Bregani, ER; Cabibbe, M | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Huerta-Guzmán, J; Murillo, E; Nambo, MJ; Neri, N; Talavera, A | 1 |
| Avilés, A; Huerta-Guzmán, J; Neri, N; Pérez, F; Sotelo, L | 1 |
| Baldinger, C; Fridrik, MA; Greil, R; Hausmaninger, H; Klocker, J; Krieger, O; Linkesch, W; Oberaigner, W; Pont, J | 1 |
| Baek, JH; Kim, DH; Kim, JG; Lee, KB; Park, TI; Sohn, SK | 1 |
| Bourgain, C; De Paepe, P; Serreyn, R; Van den Broecke, R; Van Renterghem, N | 1 |
| Angelucci, E; Baldini, L; Boccomini, C; Brugiatelli, M; Cabras, MG; Calvi, R; Ciccone, G; Deliliers, GL; Federico, M; Gallo, E; Genua, A; Levis, A; Liberati, AM; Parvis, G; Pavone, E; Salvi, F; Sborgia, M; Vitolo, U | 1 |
| Chamorey, E; Delwail, V; Fabbro, M; Foussard, C; Gressin, R; Harrousseau, JL; Lepeu, G; Maisonneuve, H; Peyrade, F; Richard, B; Rossi, JF; Thyss, A; Vilque, JP | 1 |
| Abate, G; Comella, P; Di Finizio, G; Fiore, M; Zarrilli, D | 1 |
| Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F | 1 |
| Broglia, C; Corazza, GR; Federico, M; Gobbi, PG; Lambelet, P; Lombardo, M; Luminari, S; Mammi, C; Merli, F; Polimeno, G; Riezzo, A; Rovati, A; Valentino, F | 1 |
| Chang, MC; Chang, YF; Hsieh, RK; Huang, MJ; Lin, J; Su, YW | 1 |
| Ambrosetti, A; Andreoli, A; Canal, F; Chilosi, M; Krampera, M; Lestani, M; Parolini, C; Pizzolo, G; Visco, C | 1 |
| Avilés, A; Cleto, S; Huerta-Guzman, J; Nambo, MJ; Neri, N | 2 |
| Aleman, BM; Bosq, J; Carde, P; Dupouy, N; Eghbali, H; Girinsky, T; Hagenbeek, A; Henry-Amar, M; Kluin-Nelemans, JC; Krol, AD; Monconduit, M; Noordijk, EM; Pény, AM; Raemaekers, JM; Thomas, J; Tirelli, U; Verschueren, TA; Vovk, M | 1 |
| Aurran, T; Biron, P; Bouabdallah, R; Boulat, O; Chabannon, C; Chetaille, B; Coso, D; Esterni, B; Gastaut, JA; Ivanov, V; Maraninchi, D; Rey, J; Schiano de Collela, JM; Sebban, C; Stoppa, AM; Xerri, L | 1 |
| Choi, CW; Choi, IK; Choi, JG; Kim, BS; Kim, JS; Kim, SJ; Kim, YH; Oh, SC; Park, KH; Seo, HY; Seo, JH; Shin, SW; Sul, HR; Sung, HJ | 1 |
| Kimura, M; Kobayashi, T; Miyazaki, K; Nishikawa, H; Ogawa, S; Shiku, H; Tawara, I; Ueno, S; Yamaguchi, M | 1 |
| Bahri Zouari, I; Charfi, S; Daoud, J; Gouiaa, N; Khabir, A; Sellami Boudawara, T; Toumi, N | 1 |
| Choi, CW; Jung, KY; Kim, BS; Kim, CY; Kim, IS; Kim, JS; Kim, SJ; Seo, HY; Seol, HR; Sung, HJ | 1 |
| Fortner, BV; Houts, AC; Schwartzberg, LS | 1 |
| Abbott, BL; Chen, R; Myint, H | 1 |
| Chen, CH; Chen, SW; Chen, TY; Huang, WT; Shen, WL; Tsao, CJ | 1 |
| Leonard, JP; Siegel, AB | 1 |
| Baldini, L; Bertini, M; Botto, B; Cabras, G; Di Vito, F; Federico, M; Gallo, E; Liberati, AM; Luminari, S; Marcheselli, L; Merli, F; Mozzana, R; Naglieri, E; Orsucci, L; Pennese, E; Polimeno, G; Vitolo, U | 1 |
| Doglioni, C; Dognini, GP; Ferreri, AJ; Patriarca, C; Ponzoni, M; Verona, C | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Nambo, MJ; Neri, N | 1 |
| Avilés, A; Castañeda, C; Cleto, S; Contreras, M; González, M; Huerta-Guzmàn, J; Murillo, E; Nambo, MJ; Neri, N; Talavera, A | 1 |
| de Jong, FH; de Muinck Keizer-Schrama, SM; Hakvoort-Cammel, FG; Laven, JS; Pieters, R; Themmen, AP; van Beek, RD; van den Berg, H; van den Bos, C; van den Heuvel-Eibrink, MM | 1 |
| Bu, Q; Cai, QQ; Gao, Y; Guan, ZZ; Huang, HQ; Jiang, WQ; Lin, XB; Pan, ZH; Wang, BF; Xia, ZJ; Xu, RH | 1 |
| Balzarotti, M; Isa, L; Magagnoli, M; Morenghi, E; Santoro, A; Siracusano, LV; Spina, M; Tirelli, U | 1 |
| de Jong, FH; de Muinck Keizer-Schrama, SM; Hakvoort-Cammel, FG; Pieters, R; Smit, M; van Beek, RD; van den Berg, H; van den Bos, C; van den Heuvel-Eibrink, MM; Weber, RF | 1 |
| Avilés, A | 1 |
| Brice, P; Casasnovas, O; Cazeneuve, C; Gabarre, J; Koscielny, S; Lenoir, G; Morschhauser, F; Ribrag, V; Salles, G; Stamatoullas, A | 1 |
| Bellaaj, H; Ben Salah, H; Daoud, J; Elloumi, M; Frikha, M; Ghorbel, L; Krichen, MS | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Villani, M; Viviani, S | 1 |
| Gu, YJ; Guo, X; Guo, Y; Lu, H; Ma, X; Pang, Z; Wang, B | 1 |
| Antonelli, A; Carpi, A; Cervetti, G; Fallahi, P; Franzoni, F; Galetta, F; Petrini, M; Regoli, F; Santoro, G; Tocchini, L | 1 |
| Baldini, L; Barbolini, E; Brugiatelli, M; Dell'Olio, M; Dondi, A; Federico, M; Giglio, G; Gobbi, PG; Luminari, S; Mannina, D; Merli, F; Polimeno, G; Stelitano, C | 1 |
| Ali, ZB; Ben Othmen, T; Bouaouina, N; Daoud, J; Elloumi, M; Ghannem, H; Laatiri, MA; Maalej, M; Meddeb, B; Msadek, F; Toumi, N | 1 |
| Gallamini, A; Grimaldi, F; Nicolai, E; Pane, F; Picardi, M; Soricelli, A | 1 |
| Bonfante, V; Busia, A; Laffranchi, A; Villani, F; Viviani, S | 1 |
| Barbanti, G; Bargagli, G; Chiriacò, G; Conca, R; De Rubertis, G; Fiaschi, AI; Francini, E; Francini, G; Manganelli, A; Pascucci, A; Petrioli, R; Ponchietti, R | 1 |
| Cunningham, D; Hawkes, EA; Okines, AF; Plummer, C | 1 |
| Alvarez, I; Arcari, A; Baldini, L; Chiappella, A; Di Rocco, A; Federico, M; Fragasso, A; Gobbi, PG; Ilariucci, F; Liberati, AM; Luminari, S; Mammi, C; Marcheselli, L; Mazza, P; Merli, F; Musso, M; Rossi, G; Salvi, F; Stelitano, C; Tucci, A | 1 |
| Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT | 1 |
| Dousias, V; Michos, GM; Navrozoglou, I; Papadopoulos, G; Stefos, T | 1 |
| Alexander, C; Connors, JM; Gascoyne, RD; Hamilton, SN; Tan, K; Wai, ES | 1 |
| Aisimitula, A; Fu, L; Huang, Q; Li, Y; Mao, M; Nie, Y; Wang, X; Yimamu, M; Zhang, X | 1 |
| Chen, H; Cheng, L; Kang, Y; Li, L; Pan, C; Shu, X; Sun, M; Xu, X | 1 |
| Abdi, E; Benson, W; Bonaventura, A; Browett, P; Cannell, P; Dubosq, MC; Ellis, D; Green, M; Grigg, A; Hertzberg, M; Horvath, N; Januszewicz, H; Marlton, P; Matthews, JP; Stone, JM; Wolf, M | 1 |
| Daw, S; Hayward, J; Hewitt, M; Kirkwood, A; McCarthy, K; Morland, B; Shankar, A | 1 |
| Cao, C; Kai, S; Liu, T; Wang, L; Xiang, B; Zhu, H | 1 |
| Fukushima, T | 1 |
| Avilès, A; Huerta-Guzmàn, J; Nambo, MJ; Neri, N; Silva, L | 1 |
| Advani, RH; Ansell, SM; Beaven, AW; Carson, KR; Evens, AM; Foss, F; Horwitz, S; Lechowicz, MJ; Loberiza, F; Pinter-Brown, LC; Pro, B; Savage, KJ; Shustov, AR; Smith, SM; Vose, JM | 1 |
| Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C | 1 |
| Abderrahim, K; Asma, A; Badreddine, S; Bechir, A; Haifa, R; Nesrine, A; Yosra, BY | 1 |
| Aleman, BMP; André, M; Audouin, J; Beijert, M; Bordessoule, D; Bouabdallah, K; Boulat, O; Christian, B; de Jong, D; Eghbali, H; Fermé, C; Gabarre, J; Gaillard, I; Girinsky, T; Gonzalez, H; Hélias, P; Henry-Amar, M; Jaubert, J; Lugtenburg, PJ; Lybeert, MLM; Morschhauser, F; Noordijk, EM; Ong, F; Quittet, P; Roesink, JM; Stamatoullas, A; Tertian, G; Thomas, J; Tirelli, U; van der Maazen, RWM; Vranovsky, A | 1 |
| Jantunen, E; Kuittinen, O; Peroja, P; Prusila, REI; Turpeenniemi-Hujanen, T | 1 |
| Cuvertoret-Sanz, M; Marco, A; Martínez, J; Martínez-Sogues, L; Novellas, R; Pastor, J; Roura, X; Solano-Gallego, L; Vila, A | 1 |
| Li, J; Ping, P; Sun, Y; Xu, Y; Yao, C; Yin, H | 1 |
| Bhat, G; Christina Pinto, A; Hanaganahalli Basavaiah, S; Mendonca Bryne, S; Thahir, M; Upadyaya, K | 1 |
| Ayadi, M; Bahri, O; Berjeb, KK; Braham, M; Chakroun, N; Chtourou, S; Debbabi, L; Fadhlaoui, A; Hamdoun, M; Hannachi, H; Kacem, K; Zemni, Z; Zhioua, F | 1 |
| Kuittinen, O; Kuitunen, H; Tokola, S; Turpeenniemi-Hujanen, T | 1 |
| Bai, O; Feng, X; Guo, Q; Guo, W; Li, J; Qu, L; Wang, Y; Yan, X; Young, KH; Zhao, Y | 1 |
| Wang, W; Wei, C; Zhang, W; Zhang, Y; Zhao, D; Zhou, D | 1 |
10 review(s) available for prednisone and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Treatment of relapses and failures in disseminated Hodgkin's disease].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Cytarabine; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Hodgkin Disease; Humans; Ifosfamide; Mechlorethamine; Melphalan; Methotrexate; Mitoguazone; Prednisone; Procarbazine; Remission Induction; Transplantation, Autologous; Transplantation, Homologous; Vinblastine; Vincristine | 1991 |
[Hodgkin disease: should high-risk patients be selected and chemotherapy be intensified?].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Dose-Response Relationship, Drug; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Patient Selection; Prednisone; Procarbazine; Prognosis; Risk Assessment; Sex Factors; Survival Rate; Vinblastine; Vincristine | 1995 |
Burkitt's lymphoma involving the mandible: report of a case and review of Japanese cases.
Topics: Anti-Inflammatory Agents; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Humans; Hydrocortisone; Japan; Male; Mandibular Neoplasms; Methotrexate; Prednisone; Soft Tissue Neoplasms | 1998 |
Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Prednisone; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Vincristine | 1999 |
Fludarabine combination therapy for the treatment of chronic lymphocytic leukemia.
Topics: Adolescent; Adult; Aged; Alemtuzumab; Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Chlorambucil; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Forecasting; Granulocyte Colony-Stimulating Factor; Humans; Immunotherapy; Infections; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Prednisone; Randomized Controlled Trials as Topic; Remission Induction; Rituximab; Treatment Outcome; Vidarabine; Vincristine | 2002 |
Primary lymphoma of the cervix uteri: a diagnostic challenge. Report of two cases and review of the literature.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Diagnosis, Differential; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, B-Cell; Middle Aged; Neoplasm Staging; Prednisone; Uterine Cervical Neoplasms; Vincristine; Vindesine | 2005 |
De novo CD5-positive diffuse large B-cell lymphoma of the temporal bone presenting with an external auditory canal tumor.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Bone Neoplasms; CD5 Antigens; Cyclophosphamide; Ear Canal; Ear Neoplasms; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Prednisone; Rituximab; Temporal Bone; Vincristine | 2006 |
Bortezomib-contained chemotherapy and thalidomide combined with CHOP (Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone) play promising roles in plasmablastic lymphoma: a case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Boronic Acids; Bortezomib; Cyclophosphamide; Dexamethasone; Doxorubicin; Duodenum; Epirubicin; Fatal Outcome; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Prednisone; Pyrazines; Remission Induction; Stomach; Thalidomide; Tomography, X-Ray Computed; Vincristine | 2014 |
[Treatment of adult T-cell leukemia-lymphoma].
Topics: Allografts; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cell Transplantation; Human T-lymphotropic virus 1; Humans; Interferon-alpha; Leukemia-Lymphoma, Adult T-Cell; Methotrexate; Nitrosourea Compounds; Prednisolone; Prednisone; Prognosis; Salvage Therapy; Vincristine; Vindesine; Zidovudine | 2014 |
69 trial(s) available for prednisone and epirubicin
| Article | Year |
|---|---|
Novel combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP II) before radical radiotherapy in localized stages (I-IIIA) of Hodgkin's disease. Early results in 100 consecutive patients. Pierre-et-Marie-Curie Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Combined Modality Therapy; Epirubicin; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Vinblastine | 1991 |
Phase II study of cyclophosphamide (C), epirubicin (E), oncovin (O), prednisone (P), methotrexate (M) + leucovorin and bleomycin (B) (CEOP-MB) in intermediate and high grade non-Hodgkin lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 1991 |
Cardiotoxicity of epirubicin and doxorubicin: a double-blind randomized study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Double-Blind Method; Doxorubicin; Epirubicin; Female; Heart; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myocardium; Prednisone; Radionuclide Imaging; Vincristine | 1991 |
CEOP regimen in the treatment of advanced low-grade non-Hodgkin's lymphomas: preliminary report.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Evaluation; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Remission Induction; Vincristine | 1990 |
Comparison of CHOP-B vs CEOP-B in 'poor prognosis' non-Hodgkin's lymphomas. A randomized trial.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Random Allocation; Remission Induction; Vincristine | 1989 |
Combination chemotherapy including epirubicin for the management of non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Random Allocation; Vincristine | 1987 |
Preliminary results of the EORTC-GPMC controlled clinical trial H7 in early-stage Hodgkin's disease. EORTC Lymphoma Cooperative Group. Groupe Pierre-et-Marie-Curie.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy; Salvage Therapy; Survival Rate; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Reduction of serum prostate-specific antigen during endocrine or cytotoxic treatment of hormone-resistant cancer of the prostate. A preliminary report.
Topics: Aged; Biomarkers, Tumor; Combined Modality Therapy; Epirubicin; Estramustine; Flutamide; Humans; Male; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Time Factors | 1994 |
Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Radiation; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Vincristine; Vindesine | 1994 |
Extended-field radiotherapy in favorable stage IA-IIA Hodgkin's disease (prognostic role of stage).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Risk Factors; Salvage Therapy; Vinblastine; Vincristine | 1994 |
Effect of granulocyte colony-stimulating factor in patients with diffuse large cell lymphoma treated with intensive chemotherapy.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Diseases; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Humans; Immunologic Factors; Leucovorin; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vincristine | 1994 |
P-VEBEC: a new 8-weekly schedule with or without rG-CSF for elderly patients with aggressive non-Hodgkin's lymphoma (NHL).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Neutropenia; Prednisone; Prognosis; Remission Induction; Survival Rate; Vinblastine | 1994 |
Combined therapy for angioimmunoproliferative lesions.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Granuloma, Lethal Midline; Humans; Lymphoma; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1994 |
CEOP-B alternated with VIMB in intermediate-grade and high-grade non-Hodgkin's lymphoma: a pilot study.
Topics: Actuarial Analysis; Adult; Aged; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chi-Square Distribution; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Karnofsky Performance Status; L-Lactate Dehydrogenase; Lymphoma, Non-Hodgkin; Male; Middle Aged; Mitoxantrone; Pilot Projects; Prednisone; Prognosis; Prospective Studies; Remission Induction; Survival Rate; Treatment Failure; Vincristine | 1995 |
Therapeutic strategies in intermediate grade lymphomas in elderly patients. The Italian Multiregional non Hodgkin's Lymphoma Study Group (IMRNHLSG).
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma; Prednisone; Recombinant Proteins; Survival Analysis; Time Factors; Vinblastine | 1993 |
In search of an optimal regimen for elderly patients with advanced-stage diffuse large-cell lymphoma: results of a phase II study of P/DOCE chemotherapy.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Probability; Prognosis; Prospective Studies; Treatment Outcome; Vincristine | 1993 |
[Comparison of effectiveness of adriamycin and epirubicin administered in the CHOP protocol to patients with malignant non-hodgkin's lymphoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1993 |
ProMECE-CytaBOM vs MACOP-B in advanced aggressive non-Hodgkin's lymphoma: long term results of a multicenter study of the Italian Lymphoma Study Group (GISL).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Hemoglobins; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Vincristine | 1995 |
Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Male; Melphalan; Middle Aged; Multiple Myeloma; Myeloproliferative Disorders; Peptichemio; Prednisone; Recombinant Proteins; Vincristine | 1996 |
[Biweekly cyclophosphamide, epirubicin, vincristine and prednisolone (CEOP) chemotherapy for the elderly patients with aggressive non-Hodgkin's lymphoma. Tochigi Malignant Lymphoma Study Group for the Elderly Patients].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Drug Administration Schedule; Epirubicin; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Recombinant Proteins; Remission Induction; Vincristine | 1996 |
Interferon alpha 2b as maintenance therapy in low grade malignant lymphoma improves duration of remission and survival.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Immunologic Factors; Interferon alpha-2; Interferon-alpha; Life Tables; Lymphoma, Non-Hodgkin; Male; Middle Aged; Patient Acceptance of Health Care; Prednisone; Quality of Life; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 1996 |
The treatment of elderly patients with aggressive non-Hodgkin's lymphomas: feasibility and efficacy of an intensive multidrug regimen.
Topics: Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacterial Infections; Bleomycin; Bone Marrow; Cyclophosphamide; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Ketoconazole; Lymphoma, Non-Hodgkin; Male; Mycoses; Neoplasm Staging; Ofloxacin; Prednisone; Prognosis; Prospective Studies; Recombinant Proteins; Survival Rate; Vinblastine | 1996 |
A prospective study of VEC-POB and POCE chemotherapy in aggressive non-Hodgkin's lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Humans; Lymphoma, Non-Hodgkin; Prednisone; Prospective Studies; Survival Rate; Vincristine | 1997 |
Dose escalation of epirubicin in the CEOP-BLEO regimen: a controlled clinical trial comparing standard doses for the treatment of diffuse large cell lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Survival Rate; Treatment Failure; Treatment Outcome; Vincristine | 1997 |
Epirubicin (CEOP-Bleo) versus idaurubicin (CIOP-Bleo) in the treatment of elderly patients with aggressive non-Hodgkin's lymphoma: dose escalation studies.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Idarubicin; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1997 |
High-dose intensity cyclophosphamide, epidoxorubicin, vincristine and prednisone by shortened intervals and granulocyte colony-stimulating factor in non-Hodgkin's lymphoma: a phase II study.
Topics: Adult; Aged; Antidotes; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Feasibility Studies; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1998 |
Efficacy of two different ProMACE-CytaBOM derived regimens in advanced aggressive non-Hodgkin's lymphoma. Final report of a multicenter trial conducted by GISL.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Neoplasm; Epirubicin; Etoposide; Female; Heart Diseases; Hematologic Diseases; Humans; Idarubicin; Italy; Karnofsky Performance Status; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Prognosis; Proportional Hazards Models; Remission Induction; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 1998 |
Bcl-2 gene rearrangements and apoptosis rates in patients with non-Hodgkin's lymphoma during chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cyclophosphamide; Epirubicin; Female; Gene Rearrangement; Genes, bcl-2; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Translocation, Genetic; Vincristine | 1999 |
CEOP treatment results and validity of the International Prognostic Index in Chinese patients with aggressive non-Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Reproducibility of Results; Treatment Outcome; Vincristine | 1998 |
[Epirubicin containing regimens in advanced malignant tumors report of 516 cases. Epirubicin Collaborative Study Group].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Epirubicin; Female; Humans; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prospective Studies; Vincristine | 1997 |
Granisetron plus or minus alprazolam for emesis prevention in chemotherapy of lymphomas: a randomized multicenter trial. Granisetron Trialists Group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Anti-Anxiety Agents; Antiemetics; Antineoplastic Agents; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Female; Granisetron; Humans; Lymphoma; Male; Middle Aged; Prednisone; Vomiting | 1999 |
CEOP-B/VIMB vs. promace-CytaBOM in the treatment of intermediate or high grade non-Hodgkin's lymphoma: A randomised multicenter study of Southern Italy Cooperative Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Neoplasm Staging; Prednisone; Survival Analysis; Treatment Outcome; Vincristine | 2000 |
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Efficacy of vinorelbine, epirubicin and prednisone combination regimen in pretreated elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Therapeutic Equivalency; Treatment Outcome; Vinblastine; Vinorelbine | 2001 |
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma.
Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2000 |
Treatment of refractory Hodgkin's disease with modified Stanford V program.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Remission Induction; Salvage Therapy; Survival Analysis; Vinblastine; Vincristine | 2001 |
Treatment of intermediate- and high-grade non-Hodgkin's lymphoma using CEOP versus CNOP.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Mitoxantrone; Neutropenia; Prednisolone; Prednisone; Remission Induction; Survival Rate; Treatment Outcome; Vincristine | 2002 |
Combined therapy in the treatment of primary mediastinal B-cell lymphoma: conventional versus escalated chemotherapy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lymphoma, B-Cell; Male; Mediastinal Neoplasms; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2002 |
Stage I-IIE primary non-Hodgkin's lymphoma of the testis: results of a prospective trial by the GOELAMS Study Group.
Topics: Adult; Age Factors; Aged; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Humans; Lymph Nodes; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Prospective Studies; Recurrence; Testicular Neoplasms; Time Factors; Vincristine | 2002 |
Radiotherapy versus combined therapy in early stages with bulky disease aggressive malignant lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Radiotherapy, High-Energy; Remission Induction; Treatment Outcome; Vincristine | 2003 |
Treatment of indolent B-Cell nonfollicular lymphomas: final results of the LL01 randomized trial of the Gruppo Italiano per lo Studio dei Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chlorambucil; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, B-Cell; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Recombinant Proteins; Survival Analysis; Treatment Outcome | 2003 |
Initial treatment of aggressive lymphoma with high-dose chemotherapy and autologous stem-cell support.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Melphalan; Methotrexate; Middle Aged; Prednisone; Remission Induction; Stem Cell Transplantation; Survival Analysis; Transplantation, Autologous; Vincristine; Vindesine | 2004 |
Treatment of pediatric Hodgkin disease avoiding radiotherapy: excellent outcome with the Rotterdam-HD-84-protocol.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Dacarbazine; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Netherlands; Prednisone; Procarbazine; Statistics, Nonparametric; Survival Rate; Vinblastine; Vincristine | 2004 |
Quality of life assessment in elderly patients with aggressive non-Hodgkin's Lymphoma treated with anthracycline-containing regimens. Report of a prospective study by the Intergruppo Italiano Linfomi.
Topics: Aged; Anthracyclines; Antineoplastic Combined Chemotherapy Protocols; Appetite; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Neoplasm Staging; Pain; Prednisone; Quality of Life; Sleep; Surveys and Questionnaires; Vinblastine; Vincristine | 2004 |
Adjuvant radiotherapy in stage IV diffuse large cell lymphoma improves outcome.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Life Tables; Lymphoma, Large B-Cell, Diffuse; Male; Mexico; Middle Aged; Neoplasm Staging; Prednisone; Prospective Studies; Radiotherapy, Adjuvant; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
Intensive chemotherapy in the treatment of aggressive diffuse large B-cell lymphoma: malignant lymphoma.
Topics: Adult; Aged; Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Prognosis; Risk Factors; Survival Analysis; Time Factors; Treatment Outcome; Vincristine | 2004 |
Interferon alpha 2b as maintenance therapy improves outcome in follicular lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Interferon alpha-2; Interferon-alpha; Lymphoma, Follicular; Male; Middle Aged; Prednisone; Radiotherapy, Adjuvant; Recombinant Proteins; Remission Induction; Risk; Time Factors; Treatment Outcome; Vincristine | 2004 |
Long-term results of dose density therapy in patients with aggressive lymphoma.
Topics: Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Cause of Death; Cyclophosphamide; Dexamethasone; Epirubicin; Etoposide; Humans; Ifosfamide; Longitudinal Studies; Lymphoma; Mesna; Methotrexate; Middle Aged; Prednisone; Survival Analysis; Treatment Failure; Treatment Outcome; Vincristine | 2005 |
Phase II study of cyclophosphamide,epirubicin, vincristine, prednisone, and etoposide (CEOP-E) for aggressive non-Hodgkin 's lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Risk Assessment; Risk Factors; Survival Analysis; Treatment Outcome; Vincristine | 2004 |
High dose sequential chemotherapy with autologous transplantation versus dose-dense chemotherapy MegaCEOP as first line treatment in poor-prognosis diffuse large cell lymphoma: an "Intergruppo Italiano Linfomi" randomized trial.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Melphalan; Middle Aged; Mitoxantrone; Prednisone; Prognosis; Transplantation, Autologous; Vincristine | 2005 |
Prospective randomized study comparing MEMID with a chop-like regimen in elderly patients with aggressive non-Hodgkin's lymphoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphoma, Non-Hodgkin; Male; Mitoxantrone; Neutropenia; Prednisone; Prospective Studies; Pyruvaldehyde; Survival Analysis; Thrombocytopenia; Treatment Outcome; Vincristine | 2005 |
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Pilot Projects; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2006 |
The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Dose-Response Relationship, Drug; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Methotrexate; Middle Aged; Prednisone; Vincristine | 2006 |
Surgery and chemotherapy versus chemotherapy as treatment of high-grade MALT gastric lymphoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Lymphoma, B-Cell, Marginal Zone; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Staging; Prednisone; Remission Induction; Stomach Neoplasms; Vincristine | 2006 |
Combined-modality therapy for clinical stage I or II Hodgkin's lymphoma: long-term results of the European Organisation for Research and Treatment of Cancer H7 randomized controlled trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 2006 |
A phase II trial of rituximab as adjuvant to intensive sequential chemotherapy in patients under 60 years with untreated poor-prognosis diffuse large B-cell lymphoma.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Prednisone; Prognosis; Rituximab; Survival Analysis; Transplantation, Autologous; Vincristine | 2006 |
Long term results of a randomized study performed by Intergruppo Italiano Linfomi comparing Mini-CEOP vs P-VEBEC in elderly patients with diffuse large B-cell lymphoma.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Quality of Life; Survival Rate; Time Factors; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Rituximab and dose dense chemotherapy in primary breast lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Combined Modality Therapy; Disease-Free Survival; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hematologic Diseases; Humans; Immunotherapy; Lymphoma, Non-Hodgkin; Middle Aged; Nervous System Diseases; Prednisone; Rituximab; Survival Analysis; Treatment Outcome; Vincristine | 2007 |
Dose dense (CEOP-14) vs dose dense and rituximab (CEOP-14 +R) in high-risk diffuse large cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dose-Response Relationship, Drug; Epirubicin; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2007 |
A randomized phase II study of CEOP with or without semustine as induction chemotherapy in patients with stage IE/IIE extranodal NK/T-cell lymphoma, nasal type in the upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Extranodal NK-T-Cell; Male; Middle Aged; Neoplasm Invasiveness; Nose Neoplasms; Pharyngeal Neoplasms; Prednisone; Prognosis; Radiation Injuries; Semustine; Survival Rate; Vincristine; Young Adult | 2009 |
Rituximab and dose-dense chemotherapy in primary testicular lymphoma.
Topics: Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Humans; Longitudinal Studies; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Prednisone; Rituximab; Survival Rate; Testicular Neoplasms; Vincristine | 2009 |
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bleomycin; Chromans; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Free Radical Scavengers; Glutathione; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Razoxane; Time Factors; Uric Acid; Vincristine | 2010 |
Docetaxel and epirubicin compared with docetaxel and prednisone in advanced castrate-resistant prostate cancer: a randomised phase II study.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma; Disease Progression; Docetaxel; Drug Administration Schedule; Epirubicin; Feasibility Studies; Humans; Infusions, Intravenous; Male; Middle Aged; Orchiectomy; Prednisone; Prostatic Neoplasms; Taxoids; Treatment Failure | 2011 |
Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly "fit" patients with diffuse large B-cell lymphoma: results from the ANZINT
Topics: Aged; Aged, 80 and over; Anemia; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Geriatric Assessment; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Multivariate Analysis; Neutropenia; Prednisone; Proportional Hazards Models; Prospective Studies; Rituximab; Treatment Outcome; Vincristine | 2012 |
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial.
Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2012 |
A phase III randomized trial of high-dose CEOP + filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Filgrastim; Follow-Up Studies; Granulocyte Colony-Stimulating Factor; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Recombinant Proteins; Vincristine; Young Adult | 2014 |
A phase II study of cyclophosphamide, etoposide, vincristine and prednisone (CEOP) Alternating with Pralatrexate (P) as front line therapy for patients with peripheral T-cell lymphoma (PTCL): final results from the T- cell consortium trial.
Topics: Adult; Aged; Aged, 80 and over; Aminopterin; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Kaplan-Meier Estimate; Lymphoma, T-Cell, Peripheral; Male; Middle Aged; Prednisone; Treatment Outcome; Vincristine | 2016 |
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine | 2016 |
Comparison of 36 Gy, 20 Gy, or No Radiation Therapy After 6 Cycles of EBVP Chemotherapy and Complete Remission in Early-Stage Hodgkin Lymphoma Without Risk Factors: Results of the EORT-GELA H9-F Intergroup Randomized Trial.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Disease-Free Survival; Early Termination of Clinical Trials; Epirubicin; Feasibility Studies; Female; Hodgkin Disease; Humans; Induction Chemotherapy; Male; Middle Aged; Prednisone; Radiotherapy Dosage; Risk Factors; Vinblastine; Young Adult | 2018 |
86 other study(ies) available for prednisone and epirubicin
| Article | Year |
|---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Hodgkin's disease in 63 intravenous drug users infected with human immunodeficiency virus. Gruppo Italiano Cooperativo AIDS & Tumori (GICAT).
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Opportunistic Infections; Prednisone; Procarbazine; Remission Induction; Substance Abuse, Intravenous; Survival Rate; Vinblastine; Vincristine | 1991 |
[Discordance between clinical and immunological aspects in a case of chronic B-type lymphoproliferative syndrome].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; B-Lymphocytes; Chronic Disease; Cyclophosphamide; Epirubicin; Female; Humans; Leukemia, Prolymphocytic; Phenotype; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Stereoisomerism; Vincristine | 1991 |
Primary non-Hodgkin's lymphoma of the larynx treated only by chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Laryngeal Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Vincristine | 1990 |
Evaluation of cytoreductive therapy prior to high dose treatment with autologous bone marrow transplantation in relapsed and refractory Hodgkin's disease.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carmustine; Chi-Square Distribution; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dexamethasone; Epirubicin; Etoposide; Evaluation Studies as Topic; Hodgkin Disease; Humans; Male; Melphalan; Prednisone; Premedication; Remission Induction; Vincristine | 1990 |
[The combination of epirubicin, bleomycin, vinblastine and prednisone (EBVP) before radiotherapy in localized stages of Hodgkin's disease. Phase II trials].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Drug Evaluation; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Time Factors; Vinblastine; Vincristine | 1987 |
[New combination of epirubicine, bleomycin, vinblastine and prednisone (EBVP II) before radiotherapy in localized stages of Hodgkin's disease. Phase II trial in 50 patients].
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Drug Administration Schedule; Drug Evaluation; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Prognosis; Vinblastine | 1988 |
Epirubicin in combination chemotherapy in the treatment of advanced stage non-Hodgkin's lymphomas.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cardiomyopathies; Cyclophosphamide; Doxorubicin; Drug Evaluation; Epirubicin; Female; Humans; Leukopenia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Procarbazine; Vincristine | 1987 |
[Evaluation of early treatment results in Hodgkin's disease during the cytostatic protocol containing methotrexate].
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chlorambucil; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Methotrexate; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vincristine | 1995 |
High-dose sequential chemo-radiotherapy with peripheral blood progenitor cell support for relapsed or refractory Hodgkin's disease--a 6-year update.
Topics: Actuarial Analysis; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Mechlorethamine; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Whole-Body Irradiation | 1993 |
Pediatric Hodgkin's disease in Costa Rica: twelve years' experience of primary treatment by chemotherapy alone, without staging laparotomy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cytarabine; Epirubicin; Female; Hodgkin Disease; Humans; Laparotomy; Lomustine; Male; Methotrexate; Neoplasm Staging; Prednisone; Procarbazine; Prospective Studies; Radiotherapy Dosage; Survival Analysis; Treatment Outcome; Vinblastine; Vincristine | 1994 |
Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antineoplastic Combined Chemotherapy Protocols; Base Sequence; Bleomycin; Dacarbazine; Doxorubicin; Epirubicin; Female; Herpesviridae Infections; Herpesvirus 4, Human; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Mechlorethamine; Middle Aged; Molecular Sequence Data; Pneumonia, Pneumocystis; Prednisone; Procarbazine; Survival Analysis; Tumor Virus Infections; Vinblastine; Vincristine | 1995 |
[Electrolytic changes in children with acute lymphoblastic leukemia during remission induction].
Topics: Adolescent; Allopurinol; Anions; Antineoplastic Combined Chemotherapy Protocols; Bicarbonates; Blood Urea Nitrogen; Cations; Child; Child, Preschool; Cohort Studies; Creatinine; Epirubicin; Female; Humans; Hydrocortisone; Male; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Remission Induction; Risk Factors; Serum Albumin; Uric Acid; Vincristine; Water-Electrolyte Imbalance | 1995 |
Acute myocardial infarction in man treated with epirubicin for non-Hodgkin lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Lymphoma, Non-Hodgkin; Male; Myocardial Infarction; Prednisone; Vincristine | 1995 |
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine | 1993 |
Intermediate and high grade malignant non-Hodgkin's lymphomas: preliminary results using a new combination regimen (EVE-COPEM).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Neoplasm Staging; Prednisone; Vincristine; Vindesine | 1993 |
Late cardiac toxicity of doxorubicin, epirubicin, and mitoxantrone therapy for Hodgkin's disease in adults.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Heart Diseases; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Mitoxantrone; Prednisone; Procarbazine; Ventricular Function, Left; Vincristine | 1993 |
Combined therapy for primary central nervous system lymphoma in immunocompetent patients.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Brain Neoplasms; Combined Modality Therapy; Cyclophosphamide; Dexamethasone; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Humans; Immunocompetence; Leucovorin; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisolone; Prednisone; Retrospective Studies; Survival Rate; Vincristine | 1995 |
Successful mobilisation of blood stem cells following previous autologous bone marrow transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blood Cells; Bone Marrow; Bone Marrow Transplantation; Carmustine; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Hematopoietic Stem Cells; Humans; Ifosfamide; Leukapheresis; Lymphoma, Follicular; Male; Melphalan; Methotrexate; Podophyllotoxin; Prednisolone; Prednisone; Transplantation Conditioning; Transplantation, Autologous; Vincristine | 1996 |
Treatment of relapsed non-Hodgkin's lymphoma after BEAM chemotherapy and autologous transplantation by BU/CY chemotherapy and salvage transplantation.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Doxorubicin; Epirubicin; Etoposide; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Injections, Spinal; Lymphoma, B-Cell, Marginal Zone; Male; Melphalan; Methotrexate; Prednisone; Recurrence; Remission Induction; Retreatment; Salvage Therapy; Stomach Neoplasms; Transplantation Conditioning; Tumor Lysis Syndrome; Vincristine | 1997 |
[Preliminary results of conservative combination radiotherapy and chemotherapy in early stages of Hodgkin's disease].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Epirubicin; Female; Hodgkin Disease; Humans; Incidence; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Radiation Dosage; Remission Induction; Vinblastine | 1996 |
Five-year follow-up of saliva in patients treated for lymphomas.
Topics: Adult; Aged; Aged, 80 and over; Albumins; Amylases; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Immunoglobulin A, Secretory; Leucovorin; Lymphoma; Lymphoma, Non-Hodgkin; Male; Mechlorethamine; Methotrexate; Middle Aged; Muramidase; Prednisone; Procarbazine; Saliva; Salivary Proteins and Peptides; Secretory Rate; Statistics, Nonparametric; Vinblastine; Vincristine | 1997 |
Nutritional state alterations in children with acute lymphoblastic leukemia during induction and consolidation of chemotherapy.
Topics: Adolescent; Anthropometry; Antineoplastic Combined Chemotherapy Protocols; Arm; Asparaginase; Body Constitution; Child; Child, Preschool; Cohort Studies; Cytarabine; Drug Administration Schedule; Energy Metabolism; Epirubicin; Female; Gastrointestinal Diseases; Hospitals, General; Hospitals, Pediatric; Humans; Infant; Male; Mercaptopurine; Methotrexate; Nutrition Disorders; Nutritional Status; Obesity; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Risk; Skinfold Thickness; Vincristine | 1997 |
Soluble interleukin-2 receptors (sIL-2R) in Hodgkin's disease: outcome and clinical implications.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Combined Modality Therapy; Confidence Intervals; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lymph Nodes; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Receptors, Interleukin-2; Recurrence; Reference Values; Retrospective Studies; Vinblastine; Vincristine | 1998 |
Long term follow-up of CEOP in the treatment of HIV related non-Hodgkin's lymphoma (NHL).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; New South Wales; Prednisone; Prognosis; Retrospective Studies; Survival Rate; Vincristine | 1998 |
Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF.
Topics: Adult; Anti-HIV Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Epirubicin; Female; Granulocyte Colony-Stimulating Factor; Hodgkin Disease; Humans; Lymphoma, AIDS-Related; Male; Middle Aged; Prednisone; Vinblastine | 1999 |
[Burkitt's lymphoma--a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Burkitt Lymphoma; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Methotrexate; Prednisone; Vincristine | 1999 |
Bone marrow involvement by nasal NK cell lymphoma at diagnosis is uncommon.
Topics: Adult; Aged; Aged, 80 and over; Amsacrine; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow; Chemotherapy, Adjuvant; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Humans; Immunoenzyme Techniques; In Situ Hybridization; Killer Cells, Natural; Lymphoma; Male; Methotrexate; Middle Aged; Nose Neoplasms; Prednisone; Radiotherapy; RNA, Viral; Treatment Outcome; Vincristine | 2001 |
Primary high-grade mucosa-associated lymphoid tissue-type lymphoma of the cervix presenting as a common endocervical polyp.
Topics: Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bleomycin; Cyclophosphamide; Cytarabine; Diagnosis, Differential; Epirubicin; Etoposide; Female; Humans; Hysterectomy; Immunohistochemistry; In Situ Hybridization; Lymphoma, B-Cell, Marginal Zone; Methotrexate; Middle Aged; Neoplasm Proteins; Polyps; Prednisone; Uterine Cervical Neoplasms; Vincristine | 2001 |
Tolerability of the cytoprotective agent amifostine in elderly patients receiving chemotherapy: a comparative study.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Amifostine; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma, Non-Small-Cell Lung; Cyclophosphamide; Deoxycytidine; Doxorubicin; Epirubicin; Esophageal Neoplasms; Female; Fluorouracil; Gemcitabine; Humans; Hypertension; Hypocalcemia; Hypotension; Infusions, Intravenous; Lung Neoplasms; Lymphoma, Non-Hodgkin; Male; Middle Aged; Nausea; Paclitaxel; Pancreatic Neoplasms; Platinum; Prednisone; Premedication; Retrospective Studies; Vincristine | 2001 |
T-cell-rich B-cell lymphoma. Analysis of clinical features, response to treatment, survival and comparison with diffuse large B-cell lymphoma.
Topics: Aged; Antigens, CD; Antigens, CD20; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Immunohistochemistry; Liver; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Mitoxantrone; Neoplasm Staging; Prednisolone; Prednisone; Retrospective Studies; Spleen; Survival Rate; T-Lymphocytes; Time Factors; Vincristine | 2001 |
Low-dose epirubicin in combination with cyclophosphamide, vinblastine and prednisone (mini-CEOP) for the treatment of aggressive non-Hodgkin's lymphoma in elderly patients.
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Prednisone; Remission Induction; Vinblastine | 2002 |
Regression of HTLV1 associated intracardiac lymphoma following chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Heart Neoplasms; Humans; Ifosfamide; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Prednisone; Remission Induction; Ultrasonography; Vincristine | 2002 |
Successful chemotherapy in a male patient with malignant lymphoma and Leber's hereditary optic neuropathy (LHON).
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cells, Cultured; Combined Modality Therapy; Cyclophosphamide; DNA, Mitochondrial; Drug Resistance, Neoplasm; Epirubicin; Female; Humans; Leukocytes, Mononuclear; Lymphoma, Non-Hodgkin; Male; Optic Atrophy, Hereditary, Leber; Prednisone; Remission Induction; Vincristine | 2003 |
[Primary non-Hodgkin's lymphoma of the thyroid. A case report and review of the literature].
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Middle Aged; Prednisone; Thyroid Gland; Thyroid Neoplasms; Thyroidectomy; Thyroiditis, Autoimmune; Vincristine | 2003 |
Not just another fall in the elderly. Bilateral adrenal lymphoma presenting with adrenal insufficiency causing weakness.
Topics: Accidental Falls; Adrenal Gland Neoplasms; Adrenal Insufficiency; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Examination; Causality; Cyclophosphamide; Epirubicin; Family Practice; Humans; Hyponatremia; Immunophenotyping; Lymphoma; Male; Prednisone; Primary Health Care; Tomography, X-Ray Computed; Vincristine | 2003 |
An extremely rare case of synchronous occurrence in the larynx of intravascular lymphoma and in situ squamous cell carcinoma.
Topics: Antigens, CD; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma in Situ; Carcinoma, Squamous Cell; Cyclophosphamide; Epirubicin; Humans; Immunohistochemistry; Laryngeal Neoplasms; Lymphoma; Male; Middle Aged; Prednisone; Time Factors; Treatment Outcome; Vascular Neoplasms; Vincristine | 2003 |
Adult lymphoblastic lymphoma: a retrospective analysis of 92 patients under 61 years included in the LNH87/93 trials.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Clinical Trials as Topic; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Leukemia-Lymphoma, Adult T-Cell; Male; Middle Aged; Patient Selection; Predictive Value of Tests; Prednisone; Prognosis; Recurrence; Retrospective Studies; Survival Analysis; Time Factors; Vincristine | 2003 |
Long-term follow-up of patients with intermediate or high-grade non-Hodgkin lymphoma treated with a combination of cyclophosphamide, epirubicin, vincristine, and prednisone.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Comorbidity; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Survival Rate; Vincristine | 2004 |
Preemptive use of interferon or lamivudine for hepatitis B reactivation in patients with aggressive lymphoma receiving chemotherapy.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cyclophosphamide; Epirubicin; Female; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Interferon-alpha; Lamivudine; Lymphoma; Male; Middle Aged; Prednisone; Preventive Medicine; Retrospective Studies; Reverse Transcriptase Inhibitors; Secondary Prevention; Vincristine; Virus Activation | 2004 |
Hypoxia-inducible factor 1 alpha in high-risk breast cancer: an independent prognostic parameter?
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents, Hormonal; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cohort Studies; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Life Tables; Lymphatic Metastasis; Methotrexate; Middle Aged; Neoplasm Proteins; Neoplasm Staging; Paclitaxel; Prednisone; Prognosis; Receptors, Progesterone; Risk; Survival Analysis; Tamoxifen; Taxoids; Transcription Factors; Vincristine | 2004 |
Combination chemotherapy plus low-dose involved-field radiotherapy for early clinical stage Hodgkin's lymphoma.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Hodgkin Disease; Humans; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Recurrence; Remission Induction; Treatment Outcome; Vinblastine; Vincristine | 2004 |
African Burkitt lymphoma successfully treated with CEOP polychemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Child; Cyclophosphamide; Epirubicin; Humans; Male; Prednisone; Remission Induction; Treatment Outcome; Vincristine | 2004 |
Cyclophosphamide, epirubicin, vincristine, and prednisone (CEOP) in the treatment of advanced stage non-Hodgkin's lymphomas with poor histology.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisone; Prognosis; Vincristine | 1989 |
Clinical outcome of primary gastric lymphoma treated with chemotherapy alone or surgery followed by chemotherapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Female; Humans; Lymphoma; Male; Middle Aged; Prednisone; Retrospective Studies; Stomach Neoplasms; Survival Rate; Taiwan; Vincristine | 2006 |
The impact of P53 and P21(waf1) expression on the survival of patients with the germinal center phenotype of diffuse large B-cell lymphoma.
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cell Cycle; Cohort Studies; Cyclin-Dependent Kinase Inhibitor p21; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Genes, p53; Germinal Center; Humans; Immunohistochemistry; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Proteins; Phenotype; Prednisone; Prognosis; Radiotherapy, Adjuvant; Reproducibility of Results; Rituximab; Survival Analysis; Survival Rate; Tumor Suppressor Protein p53; Vincristine | 2006 |
Prospective analysis of treatment outcome and prognostic factors in patients with T-cell lymphomas treated by CEOP-B: single institutional study.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Cells; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Lymphoma, T-Cell; Male; Middle Aged; Neutropenia; Prednisone; Prognosis; Prospective Studies; Survival Rate; Treatment Outcome; Vincristine | 2006 |
[Medullary compression revealing the presence of a follicular lymphoma: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epidural Neoplasms; Epirubicin; Female; Follow-Up Studies; Humans; Immunohistochemistry; Laminectomy; Lymphoma, Follicular; Magnetic Resonance Imaging; Prednisone; Radiotherapy Dosage; Remission Induction; Spinal Cord; Spinal Cord Compression; Thoracic Vertebrae; Time Factors; Treatment Outcome; Vincristine | 2006 |
Treatment outcome of front-line systemic chemotherapy for localized extranodal NK/T cell lymphoma in nasal and upper aerodigestive tract.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease Progression; Disease-Free Survival; Epirubicin; Female; Humans; Killer Cells, Natural; Lymphoma, T-Cell; Male; Middle Aged; Prednisone; Proportional Hazards Models; Recurrence; Remission Induction; Time Factors; Treatment Outcome; Vincristine | 2006 |
A prospective investigation of chemotherapy-induced neutropenia and quality of life.
Topics: Adaptation, Psychological; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Anxiety; Carboplatin; Cisplatin; Cyclophosphamide; Depression; Docetaxel; Doxorubicin; Epirubicin; Female; Fluorouracil; Humans; Male; Middle Aged; Neutropenia; Prednisone; Prospective Studies; Psychiatric Status Rating Scales; Psychometrics; Quality of Life; Regression Analysis; Severity of Illness Index; Sickness Impact Profile; Taxoids; Treatment Outcome; United States; Vincristine | 2006 |
Treatment of HIV-associated Burkitt Lymphoma in the presence of severe hepatic dysfunction.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Burkitt Lymphoma; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; HIV Infections; Humans; Liver Diseases; Male; Prednisone; Remission Induction; Vincristine | 2006 |
Successful allogeneic stem cell transplantation for an adult with refractory anaplastic lymphoma kinase-positive anaplastic large cell lymphoma.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dexamethasone; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, Large-Cell, Anaplastic; Prednisone; Stem Cell Transplantation; Transplantation, Homologous; Vincristine | 2007 |
Therapy for older patients with diffuse large cell lymphoma: targeting the treatment to the patient.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Humans; Lymphoma, B-Cell; Lymphoma, Large B-Cell, Diffuse; Prednisone; Treatment Outcome; Vinblastine; Vincristine | 2007 |
Re-occurrence of the CD20 molecule expression subsequent to CD20-negative relapse in diffuse large B-cell lymphoma.
Topics: Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Fatal Outcome; Gene Expression Regulation, Neoplastic; Humans; Immunologic Factors; Immunophenotyping; Immunotherapy; Lymphatic Irradiation; Lymphoma, Large B-Cell, Diffuse; Male; Neoplasm Recurrence, Local; Prednisone; Rituximab; Stomach Neoplasms; Vincristine | 2007 |
Anti-Mullerian hormone is a sensitive serum marker for gonadal function in women treated for Hodgkin's lymphoma during childhood.
Topics: Adolescent; Adult; Age Factors; Age of Onset; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Male; Mechlorethamine; Ovary; Predictive Value of Tests; Prednisone; Pregnancy; Primary Ovarian Insufficiency; Procarbazine; Remission Induction; Vinblastine; Vincristine | 2007 |
[CEOP regimen in the treatment for non-Hodgkin's lymphoma].
Topics: Adolescent; Adult; Aged; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Child; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Lymphoma, T-Cell; Male; Middle Aged; Neoplasm Staging; Neutropenia; Prednisone; Remission Induction; Retrospective Studies; Survival Analysis; Thrombocytopenia; Vincristine | 2007 |
High relapse rate after a brief chemotherapy course and involved-field radiotherapy in early-stage Hodgkin lymphoma.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Male; Middle Aged; Prednisone; Recurrence | 2007 |
Inhibin B is superior to FSH as a serum marker for spermatogenesis in men treated for Hodgkin's lymphoma with chemotherapy during childhood.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Bleomycin; Child; Dacarbazine; Doxorubicin; Epirubicin; Fertility; Follicle Stimulating Hormone; Hodgkin Disease; Humans; Inhibins; Male; Mechlorethamine; Prednisone; Procarbazine; Spermatogenesis; Time Factors; Vinblastine; Vincristine | 2007 |
Breast lymphoma.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Hormonal; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Breast Neoplasms; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Disease-Free Survival; Epirubicin; Female; Humans; Immunologic Factors; Lymphoma; Middle Aged; Prednisone; Radiotherapy; Rituximab; Survival Analysis; Vincristine | 2008 |
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Case-Control Studies; Cohort Studies; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Frequency; Glucuronosyltransferase; Hodgkin Disease; Humans; Male; Middle Aged; Pharmacogenetics; Polymorphism, Genetic; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Young Adult | 2009 |
[The value of radiotherapy in the treatment of aggressive and localised gastric lymphomas].
Topics: Academic Medical Centers; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Patient Selection; Prednisone; Prognosis; Radiotherapy Dosage; Radiotherapy, Adjuvant; Remission Induction; Stomach Neoplasms; Survival Rate; Treatment Outcome; Tunisia; Vincristine | 2009 |
Cardiopulmonary response to exercise in patients with different degrees of lung toxicity after radio-chemotherapy for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Exercise; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Radiation Injuries; Vinblastine; Vincristine; Young Adult | 2009 |
Long term outcome of patients with localized aggressive non-Hodgkin lymphoma treated with PROMECE-CYTABOM plus involved-field radiation therapy: a study by the Gruppo Italiano Studio Linfomi.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Cytarabine; Disease-Free Survival; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Multivariate Analysis; Prednisone; Radiotherapy; Retrospective Studies; Treatment Outcome; Vincristine | 2010 |
[Tunisian experience in the treatment of aggressive non Hodgkin's lymphoma in adults: about 337 patients].
Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Female; Hematopoietic Stem Cell Transplantation; Humans; Karnofsky Performance Status; Lymphoma, Large B-Cell, Diffuse; Lymphoma, Non-Hodgkin; Male; Middle Aged; Prednisolone; Prednisone; Prospective Studies; Remission Induction; Rituximab; Stem Cell Transplantation; Survival Analysis; Tunisia; Vincristine; Young Adult | 2010 |
Fused FDG-PET/contrast-enhanced CT detects occult subdiaphragmatic involvement of Hodgkin's lymphoma thereby identifying patients requiring six cycles of anthracycline-containing chemotherapy and consolidation radiation of spleen.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Contrast Media; Cyclophosphamide; Disease-Free Survival; Epirubicin; Etoposide; Female; Fluorodeoxyglucose F18; Hodgkin Disease; Humans; Kaplan-Meier Estimate; Liver; Male; Middle Aged; Neoplasm Staging; Positron-Emission Tomography; Prednisone; Prospective Studies; Radiopharmaceuticals; Recurrence; Spleen; Tomography, X-Ray Computed; Young Adult | 2011 |
Cardiopulmonary toxicity of different chemoradiotherapy combined regimens for Hodgkin's disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cardiovascular Diseases; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lung Diseases; Male; Mechlorethamine; Middle Aged; Oxygen Consumption; Prednisone; Procarbazine; Radiation Injuries; Radiotherapy; Vinblastine; Vincristine; Young Adult | 2010 |
Cardiotoxicity in patients treated with bevacizumab is potentially reversible.
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Breast Neoplasms; Capecitabine; Clinical Trials as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Deoxycytidine; Dose-Response Relationship, Drug; Doxorubicin; Drug Labeling; Early Termination of Clinical Trials; Epirubicin; Female; Fluorouracil; Heart Failure; Humans; Lymphoma, Large B-Cell, Diffuse; Meta-Analysis as Topic; Paclitaxel; Prednisone; Razoxane; Remission, Spontaneous; Rituximab; Trastuzumab; Vincristine | 2011 |
Non-Hodgkin lymphoma during the 1st trimester of pregnancy.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Humans; Lymphoma, Non-Hodgkin; Magnetic Resonance Imaging; Prednisone; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Trimester, First; Tomography, X-Ray Computed; Ultrasonography; Vincristine | 2012 |
Treatment and outcomes in patients with primary cutaneous B-cell lymphoma: the BC Cancer Agency experience.
Topics: Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Humans; Lymphoma, B-Cell; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Retrospective Studies; Rituximab; Skin Neoplasms; Treatment Outcome; Vincristine | 2013 |
Addition of rituximab to a CEOP regimen improved the outcome in the treatment of non-germinal center immunophenotype diffuse large B cell lymphoma cells with high Bcl-2 expression.
Topics: Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Female; Gene Expression; Humans; Immunophenotyping; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Proto-Oncogene Proteins c-bcl-2; Retrospective Studies; Rituximab; Treatment Outcome; Vincristine | 2014 |
Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
Topics: Antibiotics, Antineoplastic; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Cardiac Output; Cyclophosphamide; Doxorubicin; Echocardiography; Echocardiography, Three-Dimensional; Epirubicin; Female; Heart Diseases; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Predictive Value of Tests; Prednisone; Rituximab; Sensitivity and Specificity; Troponin T; Vincristine | 2014 |
Treatment outcome in children and adolescents with relapsed Hodgkin lymphoma--results of the UK HD3 relapse treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carmustine; Child; Chlorambucil; Cisplatin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Cytarabine; Dacarbazine; Dexamethasone; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Hematopoietic Stem Cell Transplantation; Hodgkin Disease; Humans; Ifosfamide; Kaplan-Meier Estimate; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisolone; Prednisone; Procarbazine; Prognosis; Radiotherapy, Adjuvant; Recurrence; Remission Induction; Retrospective Studies; Salvage Therapy; Treatment Outcome; Vinblastine; Vincristine | 2014 |
Rituximab as consolidation therapy did not improve outcome in patients with diffuse large B-cell lymphoma at complete response after dose-dense chemotherapy (CHOP-14).
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Female; Follow-Up Studies; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Staging; Prednisone; Prognosis; Remission Induction; Rituximab; Survival Rate; Vincristine; Young Adult | 2015 |
Primary B cell lymphoma of the tongue base: a case report.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Prednisone; Rituximab; Tongue Neoplasms; Vincristine | 2016 |
Treatment of diffuse large B-cell lymphoma in elderly patients: Replacing doxorubicin with either epirubicin or etoposide (VP-16).
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Drug Substitution; Epirubicin; Etoposide; Female; Follow-Up Studies; Heart Diseases; Humans; Kaplan-Meier Estimate; Lymphoma, Large B-Cell, Diffuse; Male; Matched-Pair Analysis; Prednisone; Progression-Free Survival; Retrospective Studies; Rituximab; Vincristine | 2019 |
Hypercalcemia of Malignancy in a Dog Diagnosed With Cholangiocellular Carcinoma.
Topics: Animals; Antibiotics, Antineoplastic; Bile Duct Neoplasms; Cholangiocarcinoma; Dog Diseases; Dogs; Epirubicin; Hypercalcemia; Male; Paraneoplastic Syndromes; Parathyroid Hormone-Related Protein; Prednisone | 2019 |
In vitro compatibility and stability of admixtures containing etoposide, epirubicin hydrochloride and vindesine sulphate in a single infusion bag.
Topics: Cyclophosphamide; Doxorubicin; Drug Stability; Epirubicin; Etoposide; Humans; Infusion Pumps; Lymphoma, Non-Hodgkin; Prednisone; Vincristine; Vindesine | 2019 |
An Unusual Presentation of HTLV-Associated Adult T-Cell Lymphoma/Leukemia - An Eye That Said It "A (T) LL".
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Epirubicin; Human T-lymphotropic virus 1; Humans; India; Leukemia-Lymphoma, Adult T-Cell; Male; Prednisone; T-Lymphocytes; Vincristine | 2020 |
Evaluation of ovarian reserve before and after chemotherapy.
Topics: Adolescent; Adult; Anti-Mullerian Hormone; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Breast Neoplasms; Cyclophosphamide; Dacarbazine; Docetaxel; Doxorubicin; Epirubicin; Etoposide; Female; Fertility Preservation; Fluorouracil; Hodgkin Disease; Humans; Longitudinal Studies; Luminescent Measurements; Ovarian Reserve; Prednisone; Procarbazine; Vinblastine; Vincristine; Young Adult | 2021 |
Interim and end-of-treatment PET-CT suffers from high false-positive rates in DLBCL: Biopsy is needed prior to treatment decisions.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Clinical Decision-Making; Confidence Intervals; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; False Positive Reactions; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Multivariate Analysis; Positron Emission Tomography Computed Tomography; Prednisone; Proportional Hazards Models; Rituximab; Survival Rate; Treatment Outcome; Vincristine | 2021 |
The Short-Term Efficacy and Safety of Brentuximab Vedotin Plus Cyclophosphamide, Epirubicin and Prednisone in Untreated PTCL: A Real-World, Retrospective Study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Brentuximab Vedotin; Cyclophosphamide; Epirubicin; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Retrospective Studies | 2022 |
Long-time follow-up of patients with untreated peripheral T cell lymphoma following chidamide combined with cyclophosphamide, epirubicin, vindesine, prednisone, and etoposide therapy: a single-center propensity score-matching study.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Epirubicin; Etoposide; Follow-Up Studies; Humans; Lymphoma, T-Cell, Peripheral; Prednisone; Propensity Score; Retrospective Studies; Vincristine; Vindesine | 2023 |